HAMBURG, Germany, May 22, 2025 – At SLAS Europe 2025, MGI Tech Co., Ltd. introduced PrepALL, a flexible liquid handling system, along with an updated version of the Smart8 platform. These additions expand MGI’s automation capabilities with modular design, robotics, and AI integration. The systems are intended to support workflows in genomics, drug discovery, synthetic biology, and molecular diagnostics. By offering adaptable configurations, the tools aim to help laboratories optimize throughput and resource use based on research and operational needs.
PrepALL: Compact, Affordable Automation for Flexible Pipetting
The PrepALL is designed to streamline routine and complex laboratory workflows while delivering automation. Its compact design suits space-limited labs or first-time automation users. The system provides enterprise-grade functionality at a lower cost compared to traditional high-throughput liquid handlers, providing a cost-effective option for scaling lab operations.
Key features include:
- Space-saving design: Occupies just 0.7 m², with 16 SBS deck positions (expandable to 41).
- High-precision pipetting: 8 independent channels support 0.5–1200 µL volumes with CVs (coefficients of variation) of less than 3% (1–50 µL) and <1% (50–1200 µL). It supports pLLD/cLLD, liquid level tracking, and anti-dripping, so that it reduces dead volume and improves pipetting accuracy.
- Plug-and-play setup and easy to use: Integrated with a visual system, it can achieve automatic consumables identification and automatic position calibration
- Full traceability: Built-in sensors and data logging ensure reproducibility and consistency.
Leveraging vision-based AI, PrepALL enables precise performance in laboratory applications like nucleic acid extraction, plasmid construction, sample preparation, and NGS library prep. Designed for global accessibility, it reduces cost and complexity with modular design and open APIs. PrepALL supports scaling in both entry-level and high-throughput labs without infrastructure changes.
“PrepALL represents a major leap in lab automation, giving labs of all sizes the ability to streamline complex workflows with unmatched affordability and reliability. It’s a bold step in our mission to democratize cutting-edge tools and accelerate scientific discovery worldwide.” said Dr. Christian Zimmerman, VP of Sales at MGI Europe and Africa.
Scalable Automation Ecosystem for Every Lab
MGI’s automation portfolio is built to support laboratory workflows, with an emphasis on scalability and operational simplicity. At SLAS Europe 2025, MGI is also showcasing the Smart 8 system, first launched in 2022. Smart 8 features eight-channel pipetting and smart gripper technology. The enhancement adds AI-driven pipetting optimization, which reduces cycle times by up to 20% in workflows such as nucleic acid extraction, microbial screening, and library preparation. These improvements aim to increase reproducibility and throughput while maintaining cost-efficiency, making Smart 8 an option for laboratories seeking reliable automation.
The capabilities of the Smart 8 will cater to academic institutions, biotech startups, and clinical labs, offering a competitive edge in high-throughput research. By reducing manual intervention, the system speeds up results and allows researchers to focus on analysis.
Affordable, Scalable, Smart: The MGI Automation Edge
MGI focuses on cost, scalability, and global accessibility in lab automation. Designed to democratize advanced technology, MGI empowers researchers across diverse fields – from precision medicine to agriculture – regardless of budget constraints.
MGI offers a full set of tools for lab work. Their products handle every step, starting with sample extraction and preparation, and moving through sequencing to data analysis. Everything works together under one system and brand, which helps users meet different needs without switching between platforms. This setup also makes it easier to connect different systems, which reduces steps in the lab and keeps the process simple.
MGI’s strengths have made it a reliable partner in over 100 countries, supporting progress in genomics and synthetic biology. During global health emergencies, systems such as the MGISP-960 and MGISTP-7000 have processed millions of samples. These achievements show that MGI can deliver reliable performance under demanding conditions.
MGI invites researchers, lab managers, and industry professionals to explore its latest automation solutions at SLAS Europe 2025.
About MGI Tech
MGI Tech Co., Ltd., established in 2016 and headquartered in Shenzhen, China, is a biotechnology company focused on genetic sequencing and laboratory automation. Its offerings include high-throughput sequencers, reagents, and automated sample preparation systems. These products support applications in precision medicine, clinical diagnostics, agriculture, and life sciences research. The company serves a global customer base and operates facilities across six continents. MGI’s technology is used to enable large-scale, data-driven biological analysis and improve the efficiency of laboratory workflows. With a workforce of over 2,600 employees, the company has built a presence in key international markets. In 2024, MGI reported annual revenue of approximately CNY 3.21 billion. The company continues to invest in scalable sequencing platforms and automation technologies aimed at supporting the growing demand for genomic research and clinical testing infrastructure worldwide.
About SLAS Europe 2025
The SLAS Europe 2025 Conference and Exhibition, organized by the Society for Laboratory Automation and Screening (SLAS), will be held from May 20–22, 2025, at the Congress Center Hamburg in Germany. The event focuses on three core tracks: Advances in Drug Discovery, Advances in Laboratory Automation, and Screening Applications & Diagnostics. It is designed for professionals from academia, industry, and government working in the life sciences, providing a platform for scientific exchange, technology updates, and collaborative opportunities. The program includes keynote sessions, scientific presentations, and showcases from technology providers, with a focus on current trends and practical applications in automation and screening. SLAS, founded in 2010 and headquartered in Oak Brook, IL, is a non-profit organization that supports innovation in laboratory research and technology. SLAS as an organization reports an estimated annual revenue of approximately $3.5 million.